CWA Asset Management Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79K Hold
100
﹤0.01% 716
2026
Q1
$3.67K Buy
+100
New +$4.74K ﹤0.01% 677

Other funds holding NVO

CWA Asset Management Group's NVO Position: Q2 2026 in Review

CWA Asset Management Group increased its Novo Nordisk (NVO) stake by 0.76% in Q2 2026, buying an estimated $16.1K and bringing the position to 49,879 shares worth $2.39M. The position accounts for 0.07% of the portfolio, ranked #251.

CWA Asset Management Group first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.04M in Q1 2025. 210 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CWA Asset Management Group held 49,879 shares of Novo Nordisk worth $2.39M as of Q2 2026.
  • CWA Asset Management Group bought 374 Novo Nordisk shares in Q2 2026, an estimated $16.1K.
  • Novo Nordisk made up 0.07% of CWA Asset Management Group's portfolio in Q2 2026, its #251 holding.
  • CWA Asset Management Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • CWA Asset Management Group's Novo Nordisk position peaked at $5.04M in Q1 2025.
  • 210 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.